FDA warns against 'young blood' plasma infusions for dementia, PTSD

WASHINGTON – Federal health regulators on Tuesday warned consumers against controversial "young blood" treatments - plasma infusions from young donors marketed for conditions such as Parkinson's, Alzheimer's, multiple sclerosis and post-traumatic stress disorder.

"There is no proven clinical benefit of infusion of plasma from young donors to cure, mitigate, treat or prevent these conditions and there are risks associated with the use of any plasma product," Scott Gottlieb, commissioner of the Food and Drug Administration, and Peter Marks, director of the agency's Center for Biologics Evaluation and Research, said in a statement.

http://www.startribune.com/fda-warns-against-young-blood-plasma-infusions-for-dementia-ptsd/506061232/